AI firms simulate drug trials to boost success rates, cut failures
Artificial intelligence companies are running virtual drug trials for pharmaceutical companies to improve the success rate of experimental medicines in human studies, and to identify programs worth pursuing. The global biopharmaceutical industry spends $140 billion a year on clinical testing, with only about 12% of dru